Literature DB >> 30540918

Augmenter of liver regeneration protein deficiency promotes hepatic steatosis by inducing oxidative stress and microRNA-540 expression.

Sudhir Kumar1,2, Richa Rani1,2, Rebekah Karns1, Chandrashekhar R Gandhi1,2,3.   

Abstract

Levels of augmenter of liver regeneration (ALR), a multifunctional protein, are reduced in steatohepatitis. ALR depletion from ALR flox/flox/Alb-Cre [ALR-L-knockout (KO)] mouse causes robust steatosis and apoptosis of hepatocytes, and pericellular fibrosis between 1 and 2 wk postbirth. Steatosis regresses by 4 wk upon reappearance of ALR-expressing hepatocytes. We investigated mechanisms of ALR depletion-induced steatosis. ALR-L-KO mice (1-, 2-, and 4 wk old) and Adeno-Cre-transfected ALR flox/flox hepatocytes were used for in vivo and in vitro studies. ALR depletion from hepatocytes in vivo downregulated peroxisome proliferator-activated receptor (PPAR)-α, carnitine palmitoyl transferase I (CPT1)a, peroxisomal membrane protein 70 (PMP70) (modest down-regulation), and acyl-CoA oxidase 1 (ACOX1). The markedly up-regulated (20X) novel microRNA-540 (miR-540) was identified to target PPARα, PMP70, ACOX1, and CPT1a. ALR depletion from primary hepatocytes increased oxidative stress, miR-540 expression, and steatosis and down-regulated PPARα, ACOX1, PMP70, and CPT1a expression. Anti-miR-540 mitigated ALR depletion-induced steatosis and prevented loss of PPARα, ACOX1, PMP70, and CPT1a expression. Antioxidant N-acetylcysteine and recombinant ALR (rALR) both inhibited ALR depletion-induced miR-540 expression and lipid accumulation in hepatocytes. Finally, treatment of ALR-L-KO mice with rALR between 1 and 2 wk prevented miR-540 expression, and arrested steatosis and fibrosis. We conclude that ALR deficiency-mediated oxidative stress induces generation of miR-540, which promotes steatosis by dysregulating peroxisomal and mitochondrial lipid homeostasis.-Kumar, S., Rani, R., Karns, R., Gandhi, C. R. Augmenter of liver regeneration protein deficiency promotes hepatic steatosis by inducing oxidative stress and microRNA-540 expression.

Entities:  

Keywords:  ACOX1; CPT1a; PMP70; PPARα

Mesh:

Substances:

Year:  2018        PMID: 30540918      PMCID: PMC6404588          DOI: 10.1096/fj.201802015R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.834


  50 in total

1.  Combinatorial microRNA target predictions.

Authors:  Azra Krek; Dominic Grün; Matthew N Poy; Rachel Wolf; Lauren Rosenberg; Eric J Epstein; Philip MacMenamin; Isabelle da Piedade; Kristin C Gunsalus; Markus Stoffel; Nikolaus Rajewsky
Journal:  Nat Genet       Date:  2005-04-03       Impact factor: 38.330

Review 2.  Augmenter of liver regeneration: its place in the universe of hepatic growth factors.

Authors:  A Francavilla; M Hagiya; K A Porter; L Polimeno; I Ihara; T E Starzl
Journal:  Hepatology       Date:  1994-09       Impact factor: 17.425

3.  Inhibition of DNA synthesis in cultured hepatocytes by endotoxin-conditioned medium of activated stellate cells is transforming growth factor-beta and nitric oxide-independent.

Authors:  T Uemura; C R Gandhi
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

4.  Mammalian microRNAs: experimental evaluation of novel and previously annotated genes.

Authors:  H Rosaria Chiang; Lori W Schoenfeld; J Graham Ruby; Vincent C Auyeung; Noah Spies; Daehyun Baek; Wendy K Johnston; Carsten Russ; Shujun Luo; Joshua E Babiarz; Robert Blelloch; Gary P Schroth; Chad Nusbaum; David P Bartel
Journal:  Genes Dev       Date:  2010-04-22       Impact factor: 11.361

5.  Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene.

Authors:  U Varanasi; R Chu; Q Huang; R Castellon; A V Yeldandi; J K Reddy
Journal:  J Biol Chem       Date:  1996-01-26       Impact factor: 5.157

6.  microRNA are Central Players in Anti- and Profibrotic Gene Regulation during Liver Fibrosis.

Authors:  Andrea Noetel; Monika Kwiecinski; Natalia Elfimova; Jia Huang; Margarete Odenthal
Journal:  Front Physiol       Date:  2012-03-19       Impact factor: 4.566

7.  Augmenter of liver regeneration.

Authors:  Chandrashekhar R Gandhi
Journal:  Fibrogenesis Tissue Repair       Date:  2012-07-09

8.  DIANA-miRPath v3.0: deciphering microRNA function with experimental support.

Authors:  Ioannis S Vlachos; Konstantinos Zagganas; Maria D Paraskevopoulou; Georgios Georgakilas; Dimitra Karagkouni; Thanasis Vergoulis; Theodore Dalamagas; Artemis G Hatzigeorgiou
Journal:  Nucleic Acids Res       Date:  2015-05-14       Impact factor: 16.971

9.  Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice.

Authors:  Lindsey L Kennedy; Fanyin Meng; Julie K Venter; Tianhao Zhou; Walker A Karstens; Laura A Hargrove; Nan Wu; Konstantina Kyritsi; John Greene; Pietro Invernizzi; Francesca Bernuzzi; Shannon S Glaser; Heather L Francis; Gianfranco Alpini
Journal:  Lab Invest       Date:  2016-10-24       Impact factor: 5.662

10.  A mouse tissue transcription factor atlas.

Authors:  Quan Zhou; Mingwei Liu; Xia Xia; Tongqing Gong; Jinwen Feng; Wanlin Liu; Yang Liu; Bei Zhen; Yi Wang; Chen Ding; Jun Qin
Journal:  Nat Commun       Date:  2017-04-21       Impact factor: 14.919

View more
  7 in total

1.  Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease.

Authors:  Lin Chen; Xiujuan Zhang; Li Zhang; Dongmei Zheng
Journal:  Diabetes Metab Syndr Obes       Date:  2020-10-06       Impact factor: 3.168

Review 2.  Non-coding RNA crosstalk with nuclear receptors in liver disease.

Authors:  Jianguo Wu; Laura E Nagy; Suthat Liangpunsakul; Li Wang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-01-24       Impact factor: 5.187

Review 3.  Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope.

Authors:  Khushboo S Gala; Vatsalya Vatsalya
Journal:  Cells       Date:  2020-02-25       Impact factor: 6.600

4.  Augmenter of liver regeneration regulates cellular iron homeostasis by modulating mitochondrial transport of ATP-binding cassette B8.

Authors:  Hsiang-Chun Chang; Jason Solomon Shapiro; Xinghang Jiang; Grant Senyei; Teruki Sato; Justin Geier; Konrad T Sawicki; Hossein Ardehali
Journal:  Elife       Date:  2021-04-09       Impact factor: 8.140

5.  MiR-103-3p promotes hepatic steatosis to aggravate nonalcoholic fatty liver disease by targeting of ACOX1.

Authors:  Jiexia Ding; Caixia Xia; Panpan Cen; Siying Li; Lifei Yu; Jing Zhu; Jie Jin
Journal:  Mol Biol Rep       Date:  2022-05-23       Impact factor: 2.742

6.  Inhibition of Drp1 SUMOylation by ALR protects the liver from ischemia-reperfusion injury.

Authors:  Jing Huang; Ping Xie; Yuan Dong; Wei An
Journal:  Cell Death Differ       Date:  2020-10-27       Impact factor: 15.828

Review 7.  Crosstalk between Oxidative Stress and Inflammatory Liver Injury in the Pathogenesis of Alcoholic Liver Disease.

Authors:  Yoon Mee Yang; Ye Eun Cho; Seonghwan Hwang
Journal:  Int J Mol Sci       Date:  2022-01-11       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.